The role of enzyme and substrate concentration in the evaluation of serum angiotensin converting enzyme (ACE) inhibition by enalaprilat in vitro

Biochemical Pharmacology

Volumn 42, Issue 9, 1991, Pages 1729-1737

  Weisser, Karin ^a   Schloos, Jürgen ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRILAT; HIPPURYLGLYCYLGLYCINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG CONCENTRATION; ENZYME BLOOD LEVEL; ENZYME INHIBITION; ENZYME KINETICS; HUMAN; HUMAN TISSUE; MODEL; PRIORITY JOURNAL; THEORY;

AMINO ACID SEQUENCE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENALAPRILAT; KINETICS; MATHEMATICS; MODELS, THEORETICAL; MOLECULAR SEQUENCE DATA; PEPTIDYL-DIPEPTIDASE A; PROTEIN BINDING; SPECTROPHOTOMETRY; SUPPORT, NON-U.S. GOV'T;

EID: 0026003226     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(91)90509-4     Document Type: Article

References (27)

1. Angiotensin converting enzyme inhibition: discrepancy between antihypertensive effect and suppression of enzyme activity
2. Need for plasma angiotensin measurements to investigate converting- enzyme inhibition in humans
3. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung
4. A simple radioassay for angiotensin-converting enzyme
5. A continuous spectrophotometric assay for angiotensin converting enzyme
6. Pharmacokinetics of angiotensin converting enzyme inhibitors
7. Angiotensin converting enzyme activity in human serum: relationship to enzyme inhibitor in vivo and in vitro
8. Kinetics of inhibition of angiotensin converting enzyme by captopril and by enalapril diacid
9. Biological properties of the angiotensin-converting enzyme inhibitor cilazapril
10. Inhibition of angiotensin converting enzyme by 2-(N-((S)-1-carboxy-3-phenylpropyl)-l-alanyl)-(1S,3S,5S)-2-azabicyclo(3.3.0)octane-3-carboxylic acid (Hoe 498 diacid)
11. Pharmacokinetics of the converting enzyme inhibitor cilazapril in normal volunteers and the relationship to enzyme inhibition: development of a mathematical model
12. Sensitive colorimetric assay for angiotensin converting enzyme in serum
13. A linear equation that describes the steady-state kinetics of enzymes and subcellular particles interacting with tightly bound inhibitors
14. Development of competitive enzyme immunoassays for human serum angiotensin-1-converting enzyme: a comparison of four assay configurations
15. Assay of peptidase and protease enzymes in vivo
16. 50) of an enzymatic reaction
17. Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models
18. Tight-binding inhibitors—I: Kinetic behavior
19. Kinetic properties of pulmonary angiotensin-converting enzyme. Hydrolysis of hippurylglycylglycine
20. Complex competitive and non-competitive inhibition of rat lung angiotensin-converting enzyme by inhibitors containing thiol groups captopril and SA 446
21. Inhibition of angiotensin converting enzyme: mechanism and substrate dependence
22. α-((S)-1-carboxy-3-phenylpropyl)l-lysyl-l-proline
23. Kinetics of the reversible inhibition of enzyme catalyzed reactions by tight-binding inhibitors
24. Evaluation of methods for estimating the dissociation constant of tight binding enzyme inhibitors
25. Fitting curves to data using nonlinear regression: a practical and nonmathematical review